GOSSELIES, Belgium, December 06, 2023 Regulatory News: TheraVet (ISIN: BE0974387194 – ticker: ALVET), a pioneering company in the management of osteoarticular diseases in pets, updates on the Osteosarcoma Program achievements in 2023.
TheraVet: Launch of BIOCERA-VET Canine Osteosarcoma Study Conducted by the Prestigious University of Florida finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
TheraVet: Launch of BIOCERA-VET® Canine Osteosarcoma Study Conducted by the Prestigious University of Florida streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.